Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT05897502
Other study ID # EMRP-112-047
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date July 4, 2023
Est. completion date February 29, 2024

Study information

Verified date February 2024
Source E-DA Hospital
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The purpose of this study is to assess the improvement degree of nutritional care program on the nutritional status and eating habits of hemodialysis patients


Description:

After being informed about the study and potential risks, all patients giving written Informed consent will undergo a 1-week screening period to determine eligibility For study entry. At week 0, eligible patients will be assigned to the intervention group and the control group by single-blind manner(participant) with convenience sampling. In the intervention group, the patients were trained in The Transtheoretical Model on nutritional education for 8 weeks. In the control group, the patients were trained in roution nutrition education.


Recruitment information / eligibility

Status Completed
Enrollment 43
Est. completion date February 29, 2024
Est. primary completion date July 17, 2023
Accepts healthy volunteers No
Gender All
Age group 51 Years and older
Eligibility Inclusion Criteria: 1. the biochemical value = 5.5 mg/dl or albumin value<3.8g/dL 2. BMI<23kg/m2 3. Unexpected weight loss. 4. Must be able to swallow tablets Exclusion Criteria: 1. Clinical diagnosis of Alzheimer's Disease 2. Malignant tumors, gastrointestinal cachexia, and catheterization

Study Design


Intervention

Behavioral:
multimedia education
The experimental group use multimedia education, 20 minute nutrition education courses each time, a total of 8 courses. The control group use routine education.

Locations

Country Name City State
Taiwan Liu liu.yin Kaohsiung

Sponsors (1)

Lead Sponsor Collaborator
Liu, Liu-Yin

Country where clinical trial is conducted

Taiwan, 

References & Publications (1)

Karavetian M, Elzein H, Rizk R, Jibai R, de Vries N. Nutritional education for management of osteodystrophy: Impact on serum phosphorus, quality of life, and malnutrition. Hemodial Int. 2016 Jul;20(3):432-40. doi: 10.1111/hdi.12405. Epub 2016 Feb 3. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Change from Baseline in Biochemical value (Albumine) at the third month Biochemical value (Albumine) is a validated to assess the nutritional status of hemodialysis, less than 3.8gm/dl is considered malnutrition Baseline and the third month
Primary Change from Baseline in Biochemical value (Albumine) at the fourth month Biochemical value (Albumine) is a validated to assess the nutritional status of hemodialysis, less than 3.8gm/dl is considered malnutrition Baseline and the fourth month
Primary Change from Baseline in Biochemical value (Albumine) at the sixth month Biochemical value (Albumine) is a validated to assess the nutritional status of hemodialysis, less than 3.8gm/dl is considered malnutrition Baseline and the sixth month
Primary Change from Baseline in Biochemical value( normalized protein catabolic rate) at the third month Biochemical value( normalized protein catabolic rate) is a validated to assess the nutritional status of hemodialysis, normal value greater than 1.2gm/day/k Baseline and the third month
Primary Change from Baseline in Biochemical value( normalized protein catabolic rate) at the fourth month Biochemical value( normalized protein catabolic rate) is a validated to assess the nutritional status of hemodialysis, normal value greater than 1.2gm/day/k Baseline and the fourth month
Primary Change from Baseline in Biochemical value( normalized protein catabolic rate) at the sixth month Biochemical value( normalized protein catabolic rate) is a validated to assess the nutritional status of hemodialysis, normal value greater than 1.2gm/day/k Baseline and the sitxth month
Primary Change from Baseline in Biochemical value(cholesterol )at the third month Biochemical value( cholesterol) is a validated to assess the nutritional status of hemodialysis, less than 100mg/dl is considered malnutrition Baseline and the third month
Primary Change from Baseline in Biochemical value(cholesterol )at the fourth month Biochemical value( cholesterol) is a validated to assess the nutritional status of hemodialysis, less than 100mg/dl is considered malnutrition Baseline and the fourth month
Primary Change from Baseline in Biochemical value(cholesterol )at the sixth month Biochemical value( cholesterol) is a validated to assess the nutritional status of hemodialysis, less than 100mg/dl is considered malnutrition Baseline and and the sixth month
Primary Change from Baseline in Biochemical value(creatine)at the third month Biochemical value(creatine) is a validated to assess the nutritional status of hemodialysis, less than 8-10 mg/dl before hemodialysis indicates malnutrition Baseline and the third month
Primary Change from Baseline in Biochemical value(creatine) at the fourth month Biochemical value(creatine) is a validated to assess the nutritional status of hemodialysis, less than 8-10 mg/dl before hemodialysis indicates malnutrition Baseline and the fourth month
Primary Change from Baseline in Biochemical value(creatine) at the sixth month Biochemical value(creatine) is a validated to assess the nutritional status of hemodialysis, less than 8-10 mg/dl before hemodialysis indicates malnutrition Baseline and the sixth month
Primary Change from Baseline in Biochemical value( Phosphate) at the third month Biochemical value(Phosphate) is a validated to assess the nutritional status of hemodialysis, normal value is 2.7-4.5 mg/dL Baseline and the third month
Primary Change from Baseline in Biochemical value( Phosphate) at the fourth month Biochemical value(Phosphate) is a validated to assess the nutritional status of hemodialysis, normal value is 2.7-4.5 mg/dL Baseline and the fourth month
Primary Change from Baseline in Biochemical value( Phosphate) at the sixth month Biochemical value(Phosphate) is a validated to assess the nutritional status of hemodialysis, normal value is 2.7-4.5 mg/dL Baseline and the sixth month
Primary Change from Baseline in body measurement ( Hand grip strength ) at the third month Hand grip strength is a validated to assess the nutritional status of hemodialysis, male = 30 kilograms, female = 20 kilograms, indicating a risk of frailty Baseline and the third month
Primary Change from Baseline in body measurement ( Hand grip strength ) at the fourth month Hand grip strength is a validated to assess the nutritional status of hemodialysis, male = 30 kilograms, female = 20 kilograms, indicating a risk of frailty Baseline and the fourth month
Primary Change from Baseline in body measurement ( Hand grip strength ) at the sixth month Hand grip strength is a validated to assess the nutritional status of hemodialysis, male = 30 kilograms, female = 20 kilograms, indicating a risk of frailty Baseline and the sixth month
Primary Change from Baseline in (Mini Nutritional Assessment-Short Form, MNA-SF) at the third month (Mini Nutritional Assessment-Short Form, MNA-SF) is a validated self-reported instrument to assess the nutritional status of hemodialysis,Out of 14 points. =11 points malnutrition risk. =7 points malnutrition. Baseline and the third month
Primary Change from Baseline in (Mini Nutritional Assessment-Short Form, MNA-SF) at the fourth month (Mini Nutritional Assessment-Short Form, MNA-SF) is a validated self-reported instrument to assess the nutritional status of hemodialysis,Out of 14 points. =11 points malnutrition risk. =7 points malnutrition. Baseline and the fourth month
Primary Change from Baseline in (Mini Nutritional Assessment-Short Form, MNA-SF) at the sixth month (Mini Nutritional Assessment-Short Form, MNA-SF) is a validated self-reported instrument to assess the nutritional status of hemodialysis,Out of 14 points. =11 points malnutrition risk. =7 points malnutrition. Baseline and the six month
Secondary Change from Baseline in the diet of knowledge form at the third month The diet of knowledge form is a validated self-reported instrument to assess the eating habits of hemodialysis patients,The full score is 10 points. The higher the score, the positive performance on healthy diet knowledge Baseline and the third month
Secondary Change from Baseline in the diet of knowledge form at the fourth month The diet of knowledge form is a validated self-reported instrument to assess the eating habits of hemodialysis patients,The full score is 10 points. The higher the score, the positive performance on healthy diet knowledge Baseline and the fourth month
Secondary Change from Baseline in the diet of knowledge form at the sixth month The diet of knowledge form is a validated self-reported instrument to assess the eating habits of hemodialysis patients,The full score is 10 points. The higher the score, the positive performance on healthy diet knowledge Baseline and the sixth month
Secondary Change from Baseline in the diet of attitude form at the third month The diet of attitude form is a validated self-reported instrument to assess the eating habits of hemodialysis patients,The full score is 20 points. A higher score indicates a positive attitude towards healthy eating Baseline and the third month
Secondary Change from Baseline in the diet of attitude form at the fourth month The diet of attitude form is a validated self-reported instrument to assess the eating habits of hemodialysis patients,The full score is 20 points. A higher score indicates a positive attitude towards healthy eating Baseline and the fourth month
Secondary Change from Baseline in the diet of attitude form at the sixth month The diet of attitude form is a validated self-reported instrument to assess the eating habits of hemodialysis patients,The full score is 20 points. A higher score indicates a positive attitude towards healthy eating Baseline and the sixth month
Secondary Change from Baseline in the diet of behavior form at the third month The diet of behavior form is a validated self-reported instrument to assess the eating habits of hemodialysis patients,The full score is 20 points. A higher score indicates a positive performance on healthy eating behavior Baseline and the third month
Secondary Change from Baseline in the diet of behavior form at the fourth month The diet of behavior form is a validated self-reported instrument to assess the eating habits of hemodialysis patients,The full score is 20 points. A higher score indicates a positive performance on healthy eating behavior Baseline and the fourth month
Secondary Change from Baseline in the diet of behavior form at the sixth month The diet of behavior form is a validated self-reported instrument to assess the eating habits of hemodialysis patients,The full score is 20 points. A higher score indicates a positive performance on healthy eating behavior Baseline and the sixth month
Secondary Change from Baseline in the high phosphorus food frequency questionnaire at the third month The high phosphorus food frequency questionnaire is a validated self-reported instrument to assess the eating habits of hemodialysis patients,The full score is 42. The higher the score, the negative the frequency of food intake with high phosphorus. Baseline and the third month
Secondary Change from Baseline in the high phosphorus food frequency questionnaire at the fourth month The high phosphorus food frequency questionnaire is a validated self-reported instrument to assess the eating habits of hemodialysis patients,The full score is 42. The higher the score, the negative the frequency of food intake with high phosphorus. Baseline and the fourth month
Secondary Change from Baseline in the high phosphorus food frequency questionnaire at the sixth month The high phosphorus food frequency questionnaire is a validated self-reported instrument to assess the eating habits of hemodialysis patients,The full score is 42. The higher the score, the negative the frequency of food intake with high phosphorus. Baseline and the sixth month
Secondary Change from Baseline in the six major food frequency questionnaire at the third month The six major food frequency questionnaire is a validated self-reported instrument to assess the eating habits of hemodialysis patients,Full score is 12 points. A higher score indicates a balanced performance on the six major food intake frequencies Baseline and the third month
Secondary Change from Baseline in the six major food frequency questionnaire at the fourth month The six major food frequency questionnaire is a validated self-reported instrument to assess the eating habits of hemodialysis patients,Full score is 12 points. A higher score indicates a balanced performance on the six major food intake frequencies Baseline and the fourth month
Secondary Change from Baseline in the six major food frequency questionnaire at the sixth month The six major food frequency questionnaire is a validated self-reported instrument to assess the eating habits of hemodialysis patients,Full score is 12 points. A higher score indicates a balanced performance on the six major food intake frequencies Baseline and the sixth month
See also
  Status Clinical Trial Phase
Enrolling by invitation NCT02237534 - Lanthanum Versus Calcium Carbonate for Vascular Abnormalities in Patients With CKD and Hyperphosphatemia Phase 4
Completed NCT01252771 - Phosphate Kinetic Modeling 2 Phase 4
Completed NCT01187628 - Long-term Study in Chronic Kidney Disease (Extension From Study 14817) Phase 3
Unknown status NCT01245517 - The Influence of Dietary Phosphorus Education Program on Nutritional Status and Serum Phosphate Level Among Hemodialysis Patient N/A
Completed NCT00506441 - A Phase 3, Randomized, Double Blind, Placebo-Controlled, Multi-Center, Withdrawal Study of MCI-196 in CKD on Dialysis With Hyperphosphatemia Phase 3
Recruiting NCT04440696 - To Evaluate the Patient Tolerance, Pharmacodynamics and Pharmacokinetics of Lanthanum Polystyrene Sulfonate Powder Phase 1/Phase 2
Completed NCT01976572 - Drug-Drug Interaction Study to Evaluate the Effect of Colestilan on the Pharmacokinetics of Single Doses of Candesartan Cilexetil in Healthy Subjects Phase 1
Completed NCT01742585 - A Phase 3 Study of ASP1585 in Chronic Kidney Disease Patients With Hyperphosphatemia Not on Dialysis Phase 3
Completed NCT01191255 - A 58-Week Safety and Efficacy Trial of Ferric Citrate in Patients With ESRD on Dialysis Phase 3
Completed NCT01003223 - Phosphate Kinetic Modeling N/A
Completed NCT00505037 - A Phase 2 Study of ASP1585 in Chronic Kidney Disease Patients With Hyperphosphatemia on Hemodialysis Phase 2
Completed NCT00508885 - The Effect of Oral Niacinamide on Plasma Phosphorus Levels in Peritoneal Dialysis Patients Phase 1/Phase 2
Completed NCT04551300 - A Phase 2 Study to Evaluate the Safety and Efficacy of VS-505(AP301) to Treat Hyperphosphatemia in Hemodialysis Patients Phase 2
Completed NCT01955876 - Fosrenol Post-marketing Surveillance in Japan N/A
Completed NCT04579315 - Long-term Effects of the New Nordic Renal Diet in Patients With Moderate Chronic Kidney Disease N/A
Completed NCT03861247 - Individualized Treatment of Hyperphosphatemia in Maintenance Hemodialysis Patients Phase 3
Terminated NCT01725113 - Management of Mineral and Bone Disease in Hemodialysis-Calcitriol vs. Paricalcitol Phase 4
Recruiting NCT01238588 - The Effect(s) of Sevelamer Carbonate (Renvela) on Atherosclerotic Plaque Inflammation Judged by FDG-PET Scan N/A
Completed NCT00542815 - A Study of MCI-196 in Chronic Kidney Disease Stage V Subjects on Dialysis With Hyperphosphatemia Phase 3
Completed NCT04549597 - Study to Evaluate the Use of Tenapanor as Core Therapy in the Treatment of Hyperphosphatemia Phase 4